Interleukin 17 Inhibitors Promising in Ankylosing Spondylitis Patients

In patients with active ankylosing spondylitis, IL-17 inhibitors have produced favorable responses, according to recent research...

Source: The Rheumatologist - July 10, 2020 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates Source Type: research